California is on the cusp of a demographic shift, with the number of people 65 and older skyrocketing by 59% over the next 15 ...

Clinical trials are underway or completed for at least seven Alzheimer’s vaccines designed to harness the immune system to rid the brain of the disease-related proteins beta amyloid or tau, a ...

Nonmodifiable risk factors for DLB include age and family history. Risk increases substantially in individuals with a ...

Scientists have used AI to re-analyse a clinical trial for an Alzheimer’s medicine, and identified a group of patients who ...

University of New Mexico researchers have received funding to launch an early-stage clinical trial of a vaccine engineered to ...

UNM health scientists are seeking funding from the Alzheimer's Association and other venture capitalists to launch phase 1 of ...

Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...

- Commonly used Alzheimer's clinical trial exclusion criteria have the potential to disproportionately affect African Americans and Hispanics/Latinos, ...

In clinical trials for Alzheimer’s drugs, genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information remained secret.

A team of scientists at UCL have found that blood tests measuring the hallmark Alzheimer's protein, b-amyloid (amyloid), could radically reduce the cost of clinical trials and potentially open the ...

Although older Black Americans have twice the rate of dementia as whites, they were screened out of clinical trials of these drugs at a higher rate, according to interviews with 10 researchers as ...

A significant challenge in developing therapy and care for Alzheimer’s disease that work for people of different ethnic and racial backgrounds is recruitment and retention of traditionally ...